Literature DB >> 29380456

Uterine natural killer cell progenitor populations predict successful implantation in women with endometriosis-associated infertility.

Louise E Glover1,2,3,4, David Crosby1,2,3,4, Uma Thiruchelvam3,4, Cathal Harmon3,4, Cáit Ni Chorcora3,4, Mary B Wingfield1,2,3,4, Cliona O'Farrelly3,4.   

Abstract

PROBLEM: Uterine natural killer (uNK) cells play a critical role early in gestation. As we previously identified altered uNK cell development in endometriosis-associated infertility, we herein sought to characterize natural killer (NK) cell profiles in endometriosis that may predict embryo implantation. METHOD OF STUDY: Study participants had a surgical diagnosis of endometriosis-associated infertility. Endometrial tissue and peripheral blood were obtained from 58 women. Thirty-three patients underwent artificial reproductive technology (IVF, ICSI, or IUI) within a mean of 9.5 months of surgery. NK and hematopoietic progenitor cells from endometrium and blood were analyzed by flow cytometry. Successful implantation was defined as a positive pregnancy test.
RESULTS: In successful implantation, populations of endometrial CD34+ hematopoietic stem cells were higher (3.97% vs 0.69%; P < .0004), and coexpression of NK cell marker CD56 was increased (81.1% vs 60.9%; P < .034) compared with patients who had failed implantation. In contrast, levels of blood NK progenitors were similar in both groups.
CONCLUSION: Our study revealed that uterine NK progenitor cell populations are markedly different in patients with endometriosis who proceed to successful or failed embryo implantation and may define a novel predictor of implantation success. Our findings also highlight the fundamental differences inherent in NK cell repertoires between blood and uterine compartments.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  endometriosis; hematopoietic stem cell; implantation; uterine natural killer cell

Mesh:

Substances:

Year:  2018        PMID: 29380456     DOI: 10.1111/aji.12817

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  7 in total

Review 1.  Leonurine: From Gynecologic Medicine to Pleiotropic Agent.

Authors:  Yun-Yun Li; Yi-Kong Lin; Xin-Hua Liu; Li Wang; Min Yu; Da-Jin Li; Yi-Zhun Zhu; Mei-Rong Du
Journal:  Chin J Integr Med       Date:  2019-05-08       Impact factor: 1.978

Review 2.  Tissue-resident immunity in the female and male reproductive tract.

Authors:  Dennis Yüzen; Petra Clara Arck; Kristin Thiele
Journal:  Semin Immunopathol       Date:  2022-04-29       Impact factor: 11.759

3.  The dynamic changes in the number of uterine natural killer cells are specific to the eutopic but not to the ectopic endometrium in women and in a baboon model of endometriosis.

Authors:  Josephine A Drury; Kirstin L Parkin; Lucy Coyne; Emma Giuliani; Asgerally T Fazleabas; Dharani K Hapangama
Journal:  Reprod Biol Endocrinol       Date:  2018-07-18       Impact factor: 5.211

Review 4.  On the Way to Become a Natural Killer Cell.

Authors:  Clara Di Vito; Joanna Mikulak; Domenico Mavilio
Journal:  Front Immunol       Date:  2019-08-02       Impact factor: 7.561

Review 5.  Dynamic Function and Composition Changes of Immune Cells During Normal and Pathological Pregnancy at the Maternal-Fetal Interface.

Authors:  Fenglian Yang; Qingliang Zheng; Liping Jin
Journal:  Front Immunol       Date:  2019-10-18       Impact factor: 7.561

6.  Transcriptomic analysis shows that surgical treatment is likely to influence the endometrial receptivity of patients with stage III/IV endometriosis.

Authors:  Rui Xiang; Peigen Chen; Zhi Zeng; Huijun Liu; Juan Zhou; Chuanchuan Zhou; Jintao Peng; Haitao Zeng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-29       Impact factor: 6.055

7.  Circulating CD56+ NKG2D+ NK cells and postoperative fertility in ovarian endometrioma.

Authors:  Zhi-Qin Liu; Mei-Yin Lu; Bin Liu
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.